arrow_back Back to App

Easier Access to Affordable Generic Drugs with Medical Devices

This act aims to simplify the market entry of more affordable generic drugs designed for use with medical devices. This could give citizens access to more budget-friendly treatment options, potentially lowering healthcare costs. The changes ensure that generic versions of drug-device combinations are as safe and effective as their more expensive counterparts.
Key points
Increased availability of cheaper generic drugs, potentially reducing treatment costs.
Ensuring generic drugs used with medical devices have the same clinical effect and safety profile as original versions.
Introducing new data requirements to confirm the efficacy and safety of generic drug-device combinations.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5158
Sponsor: Rep. Scholten, Hillary J. [D-MI-3]
Process start date: 2025-09-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fair Price Device Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5158.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-04.

What are the main provisions?

Key points include:

  • Increased availability of cheaper generic drugs, potentially reducing treatment costs.
  • Ensuring generic drugs used with medical devices have the same clinical effect and safety profile as original versions.
  • Introducing new data requirements to confirm the efficacy and safety of generic drug-device combinations.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Scholten, Hillary J. [D-MI-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health